ASN002
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ASN002, covering 2022-11-15 to 2023-09-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]